Facebook
Twitter
Telegram
Report an ErrorArmata Pharmaceuticals Balance Sheet 2011-2024 | ARMP
Annual Balance Sheet Armata Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
54.6 M | 34 M | 27.7 M | 3.5 M | -3.17 M | -8.16 M | -5.13 M | -4.91 M | -9.37 M | -6.58 M | -20.4 M | 2.79 M | 1.6 M |
Long Term Debt |
58.6 M | 31.8 M | 36.5 M | - | - | - | - | - | - | - | - | - | 2.7 M |
Long Term Debt Current |
9.48 M | 17 M | 1.51 M | 1.55 M | 1.31 M | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | 14 M | 5.98 M | 841 K | 1.44 M | 4.89 M | 16.4 M | 23.3 M | 50 M | 3.08 M | 2.82 M |
Total Current Liabilities |
16.5 M | 24.9 M | 4.81 M | 6.7 M | 4.88 M | 2.57 M | 1.97 M | 3.58 M | 2.38 M | 1.87 M | - | - | - |
Total Liabilities |
130 M | 59.8 M | 44.4 M | 20.7 M | 10.9 M | 3.41 M | 3.41 M | 8.47 M | 18.8 M | 25.2 M | 52.2 M | 9.13 M | 4.33 M |
Deferred Revenue |
- | - | - | - | - | - | - | - | 245 K | 244 K | - | - | - |
Retained Earnings |
-309 M | -240 M | -203 M | -180 M | -158 M | -406 M | -394 M | -381 M | -363 M | -362 M | -387 M | -321 M | -319 M |
Total Assets |
98.4 M | 95.8 M | 69.8 M | 39.5 M | 25.5 M | 11.9 M | 11.1 M | 18.2 M | 31.5 M | 28.6 M | 37.9 M | 22.1 M | 11.5 M |
Cash and Cash Equivalents |
13.5 M | 14.9 M | 10.3 M | 9.65 M | 6.03 M | 8.16 M | 5.13 M | 5.71 M | 9.37 M | 6.58 M | 20.4 M | - | - |
Book Value |
-32.1 M | 36.1 M | 25.4 M | 18.9 M | 14.6 M | 8.47 M | 7.73 M | 9.72 M | 12.7 M | 3.44 M | -14.2 M | 12.9 M | 7.15 M |
Total Shareholders Equity |
-32.1 M | 36.1 M | 25.4 M | 18.9 M | 14.6 M | 7.69 M | 7.73 M | 9.72 M | 12.7 M | 3.44 M | -22.6 M | - | - |
All numbers in USD currency
Quarterly Balance Sheet Armata Pharmaceuticals
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
28.4 M | 58.6 M | 49.7 M | 27.4 M | 31.8 M | 31.8 M | 37.2 M | 37.2 M | 36.9 M | 36.5 M | 10.6 M | 10.7 M | 10.8 M | 10.9 M | 10.9 M | 10.9 M | 10.9 M | 1.56 M | 1.56 M | 1.56 M | 1.56 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 23.4 M | 49.6 M | 69.5 M | 60.7 M | 51.1 M | 51.1 M | 50 M | - | - | - | - | - | - | - | - |
Total Liabilities |
177 M | 130 M | 125 M | 82.1 M | 86.3 M | 59.8 M | 47.3 M | 47.7 M | 46.2 M | 44.4 M | 18.9 M | 19.7 M | 18.8 M | 20.7 M | 20.7 M | 20.7 M | 20.7 M | 10.9 M | 10.9 M | 10.9 M | 10.9 M | 6.85 M | 6.85 M | 6.85 M | 3.41 M | 3.41 M | 3.41 M | 3.41 M | 3.41 M | 8.43 M | 8.43 M | 8.43 M | 8.47 M | 6.89 M | 6.89 M | 6.89 M | 6.89 M | 23.2 M | 23.2 M | 23.2 M | 23.2 M | 63.1 M | 63.1 M | 63.1 M | 63.1 M | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 20 K | 58 K | 86 K | - | 18 K | 43 K | 142 K | 245 K | 245 K | 245 K | 245 K | 244 K | 244 K | 244 K | 244 K | 244 K | 244 K | 244 K | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-334 M | -309 M | -289 M | -258 M | -254 M | -240 M | -229 M | -221 M | -212 M | -203 M | -197 M | -191 M | -185 M | -180 M | -180 M | -180 M | -180 M | -158 M | -158 M | -158 M | -158 M | -138 M | -138 M | -138 M | -406 M | -394 M | -394 M | -394 M | -394 M | -381 M | -381 M | -381 M | -381 M | -363 M | -363 M | -363 M | -363 M | -362 M | -362 M | -362 M | -362 M | -385 M | -385 M | -385 M | -385 M | - | - | - | - | - | - | - | - |
Total Assets |
120 M | 98.4 M | 113 M | 101 M | 109 M | 95.8 M | 92.9 M | 101 M | 108 M | 69.8 M | 42.7 M | 48.3 M | 52.8 M | 39.5 M | 39.5 M | 39.5 M | 39.5 M | 25.5 M | 25.5 M | 25.5 M | 25.5 M | 14.5 M | 14.5 M | 14.5 M | 11.9 M | 11.1 M | 11.1 M | 11.1 M | 11.1 M | 18.2 M | 18.2 M | 18.2 M | 18.2 M | 31.5 M | 31.5 M | 31.5 M | 31.5 M | 28.6 M | 28.6 M | 28.6 M | 28.6 M | 41.2 M | 41.2 M | 41.2 M | 41.2 M | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
37.9 M | 13.5 M | 24 M | 12.5 M | 25.1 M | 14.9 M | 25.4 M | 37 M | 46.4 M | 10.3 M | 12.1 M | 17.5 M | 22.5 M | 9.65 M | 9.65 M | 9.65 M | 9.65 M | 6.03 M | 6.03 M | 6.03 M | 6.03 M | 9.66 M | 9.66 M | 9.66 M | 8.16 M | 5.13 M | 5.13 M | 5.13 M | 5.13 M | 5.13 M | 5.71 M | 5.71 M | 5.71 M | 9.37 M | 9.37 M | 9.37 M | 9.37 M | 6.58 M | 6.58 M | 6.58 M | 6.58 M | 20.4 M | 20.4 M | 20.4 M | 20.4 M | 862 K | - | - | - | - | - | - | - |
Book Value |
-56.5 M | -32.1 M | -12.4 M | 19.1 M | 22.4 M | 36.1 M | 45.6 M | 53.3 M | 61.5 M | 25.4 M | 23.8 M | 28.6 M | 34 M | 18.9 M | 18.9 M | 18.9 M | 18.9 M | 14.6 M | 14.6 M | 14.6 M | 14.6 M | 7.69 M | 7.69 M | 7.69 M | 8.47 M | 7.73 M | 7.73 M | 7.73 M | 7.73 M | 9.72 M | 9.72 M | 9.72 M | 9.72 M | 24.6 M | 24.6 M | 24.6 M | 24.6 M | 5.43 M | 5.43 M | 5.43 M | 5.43 M | -21.9 M | -21.9 M | -21.9 M | -21.9 M | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
-56.5 M | -32.1 M | -12.4 M | 19.1 M | 22.4 M | 36.1 M | 45.6 M | 53.3 M | 61.5 M | 25.4 M | 23.8 M | 28.6 M | 34 M | 18.9 M | 18.9 M | 18.9 M | 18.9 M | 14.6 M | 14.6 M | 14.6 M | 14.6 M | 7.69 M | 7.69 M | 7.69 M | 8.47 M | 24.3 M | 7.73 M | 7.73 M | 7.73 M | 9.72 M | 9.72 M | 9.72 M | 9.72 M | 12.7 M | 12.7 M | 12.7 M | 12.7 M | 3.44 M | 3.44 M | 3.44 M | 3.44 M | -22.6 M | -22.6 M | -22.6 M | -22.6 M | 12.9 M | - | - | - | - | - | - | - |
All numbers in USD currency